EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preoperative Inflammatory Status and Postoperative Morbidity in Patients With Primary Retroperitoneal Sarcoma

Pia van der Laan, Fabio Tirotta iD, Stijn van der Burg, Stefanie Hakkesteegt, Max L Almond, Yvonne Schrage, Anant Desai, Winette T A van der Graaf, Dirk J Grunhagen iD, Samuel J Ford, Cornelis Verhoef, Winan J van Houdt

Cancer Medicine · 2025

DOI: 10.1002/cam4.70588 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Pia van der Laan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Retroperitoneal Neoplasms, Sarcoma, Postoperative Complications, Inflammation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The role of preoperative inflammatory markers in predicting postoperative outcomes has been investigated in different types of cancer. However, little is known about retroperitoneal sarcoma (RPS). This study aimed to evaluate the association between preoperative inflammatory status and major postoperative morbidity in patients undergoing RPS surgery.

Methods

Data on patients undergoing surgery for primary RPS between 2008 and 2022 at three specialist sarcoma centers were analyzed. The preoperative inflammatory status was evaluated, assessing the C‐reactive protein (CRP) value, the neutrophil/lymphocyte ratio (NLR), and the platelet/lymphocyte ratio (PLR). The primary outcome was 90‐day major postoperative morbidity. The best‐balanced cutoff values to apply in the uni‐ and multivariable analysis were calculated using a receiver operating characteristic (ROC) curve analysis.

Results

Data were available for 239 patients. Major postoperative complications occurred in 52 of 235 patients (22.1%). Increased median values of CRP, NLR, and PLR were significantly higher in patients with dedifferentiated liposarcoma (DDLPS) ( p < 0.001). As such, further analysis focused only on this specific histotype. On multivariable analysis, after adjusting for potential confounders, the association between increasing CRP and NLR with 90‐day major postoperative morbidity remained significant, with an OR of 2.96 (95% CI: 1.03–8.49, p = 0.044) for CRP > 61 mg/L, and with an OR of 4.69 (1.55–14.20, p = 0.006) for NLR > 4.85.

Conclusion

Elevated preoperative levels of CRP and NLR are independently associated with major postoperative morbidity in patients affected by primary retroperitoneal DDLPS. These findings may help decision‐making and optimize perioperative management in these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retroperitoneal NeoplasmsSarcomaPostoperative ComplicationsInflammationHumansMaleFemaleMiddle AgedAgedC-Reactive ProteinAdultPreoperative PeriodNeutrophilsRetrospective StudiesLymphocytes

Stichwörter der Autor:innen

C‐reactive proteinliposarcomaneutrophil‐to‐lymphocyte ratiopostoperative complicationsretroperitoneal sarcoma

Substanzen

C-Reactive Protein

Autor:innen und Institutionen

  • Department of Surgery, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Department of Sarcoma and General Surgery, Midlands Abdominal and Retroperitoneal Sarcoma Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Department of Surgical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
  • Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands.

ORCID-Profile: Fabio Tirotta, Dirk J Grunhagen

Zitieren

APA

van der Laan, P., Tirotta, F., van der Burg, S., Hakkesteegt, S., Almond, M. L., Schrage, Y., Desai, A., van der Graaf, W. T. A., Grunhagen, D. J., Ford, S. J., Verhoef, C., & van Houdt, W. J. (2025). Preoperative Inflammatory Status and Postoperative Morbidity in Patients With Primary Retroperitoneal Sarcoma. Cancer Medicine. https://doi.org/10.1002/cam4.70588

Vancouver

van der Laan P, Tirotta F, van der Burg S, Hakkesteegt S, Almond ML, Schrage Y, et al. Preoperative Inflammatory Status and Postoperative Morbidity in Patients With Primary Retroperitoneal Sarcoma. Cancer Medicine. 2025. doi:10.1002/cam4.70588

BibTeX
@article{vanderLaan2025,
  author = {van der Laan, Pia and Tirotta, Fabio and van der Burg, Stijn and Hakkesteegt, Stefanie and Almond, Max L and Schrage, Yvonne and Desai, Anant and van der Graaf, Winette T A and Grunhagen, Dirk J and Ford, Samuel J and Verhoef, Cornelis and van Houdt, Winan J},
  title = {Preoperative Inflammatory Status and Postoperative Morbidity in Patients With Primary Retroperitoneal Sarcoma},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.70588}
}
Kostenlos starten →